Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001671927-24-000011
Filing Date
2024-11-06
Accepted
2024-11-06 07:00:49
Documents
61
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q imcr-20240930.htm   iXBRL 10-Q 1028002
2 EX-31.1 imcr-ex311q3.htm EX-31.1 11073
3 EX-31.2 imcr-ex312q3.htm EX-31.2 11213
4 EX-32.1 imcr-ex321q3.htm EX-32.1 7393
  Complete submission text file 0001671927-24-000011.txt   5134518

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imcr-20240930.xsd EX-101.SCH 34741
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imcr-20240930_cal.xml EX-101.CAL 60502
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imcr-20240930_def.xml EX-101.DEF 158070
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imcr-20240930_lab.xml EX-101.LAB 513916
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imcr-20240930_pre.xml EX-101.PRE 341941
64 EXTRACTED XBRL INSTANCE DOCUMENT imcr-20240930_htm.xml XML 555214
Mailing Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY
Business Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY 01235 5430281
Immunocore Holdings plc (Filer) CIK: 0001671927 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39992 | Film No.: 241429186
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)